nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—LRP2—retina—malignant glioma	0.0695	0.216	CbGeAlD
Gentamicin—LRP2—medulla oblongata—malignant glioma	0.0502	0.156	CbGeAlD
Gentamicin—LRP2—midbrain—malignant glioma	0.0459	0.143	CbGeAlD
Gentamicin—LRP2—spinal cord—malignant glioma	0.0448	0.139	CbGeAlD
Gentamicin—Nephrotoxicity—Carmustine—malignant glioma	0.037	0.0779	CcSEcCtD
Gentamicin—LRP2—central nervous system—malignant glioma	0.0363	0.113	CbGeAlD
Gentamicin—LRP2—cerebellum—malignant glioma	0.0355	0.11	CbGeAlD
Gentamicin—LRP2—brain—malignant glioma	0.0288	0.0896	CbGeAlD
Gentamicin—Pulmonary fibrosis—Carmustine—malignant glioma	0.0268	0.0563	CcSEcCtD
Gentamicin—Pulmonary fibrosis—Temozolomide—malignant glioma	0.0259	0.0544	CcSEcCtD
Gentamicin—Nephropathy toxic—Carmustine—malignant glioma	0.0205	0.0431	CcSEcCtD
Gentamicin—Encephalopathy—Carmustine—malignant glioma	0.0183	0.0386	CcSEcCtD
Gentamicin—Injection site pain—Carmustine—malignant glioma	0.0144	0.0304	CcSEcCtD
Gentamicin—Extravasation—Carmustine—malignant glioma	0.0135	0.0284	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—SOD1—malignant glioma	0.013	0.0639	CbGpPWpGaD
Gentamicin—Hearing impaired—Temozolomide—malignant glioma	0.012	0.0252	CcSEcCtD
Gentamicin—SLC22A6—brain—malignant glioma	0.0109	0.0338	CbGeAlD
Gentamicin—Phlebitis—Carmustine—malignant glioma	0.00992	0.0209	CcSEcCtD
Gentamicin—Vascular purpura—Temozolomide—malignant glioma	0.00923	0.0194	CcSEcCtD
Gentamicin—Deafness—Temozolomide—malignant glioma	0.00923	0.0194	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—F2—malignant glioma	0.00902	0.0444	CbGpPWpGaD
Gentamicin—Purpura—Temozolomide—malignant glioma	0.00857	0.018	CcSEcCtD
Gentamicin—Hypokalaemia—Carmustine—malignant glioma	0.00778	0.0164	CcSEcCtD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—PIK3CA—malignant glioma	0.00763	0.0376	CbGpPWpGaD
Gentamicin—Muscular weakness—Carmustine—malignant glioma	0.00754	0.0159	CcSEcCtD
Gentamicin—Hypokalaemia—Temozolomide—malignant glioma	0.00752	0.0158	CcSEcCtD
Gentamicin—Muscular weakness—Temozolomide—malignant glioma	0.00728	0.0153	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—IFNG—malignant glioma	0.00684	0.0337	CbGpPWpGaD
Gentamicin—Weight decreased—Temozolomide—malignant glioma	0.00646	0.0136	CcSEcCtD
Gentamicin—Neuropathy peripheral—Carmustine—malignant glioma	0.00645	0.0136	CcSEcCtD
Gentamicin—Stomatitis—Carmustine—malignant glioma	0.00642	0.0135	CcSEcCtD
Gentamicin—Neuropathy peripheral—Temozolomide—malignant glioma	0.00624	0.0131	CcSEcCtD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—AKT1—malignant glioma	0.00623	0.0307	CbGpPWpGaD
Gentamicin—Stomatitis—Temozolomide—malignant glioma	0.0062	0.0131	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—IL1B—malignant glioma	0.0061	0.03	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Carmustine—malignant glioma	0.00588	0.0124	CcSEcCtD
Gentamicin—Hallucination—Carmustine—malignant glioma	0.00588	0.0124	CcSEcCtD
Gentamicin—Visual impairment—Carmustine—malignant glioma	0.0057	0.012	CcSEcCtD
Gentamicin—Hypoaesthesia—Temozolomide—malignant glioma	0.00568	0.012	CcSEcCtD
Gentamicin—Hallucination—Temozolomide—malignant glioma	0.00568	0.012	CcSEcCtD
Gentamicin—Visual impairment—Temozolomide—malignant glioma	0.00551	0.0116	CcSEcCtD
Gentamicin—Tinnitus—Temozolomide—malignant glioma	0.00533	0.0112	CcSEcCtD
Gentamicin—Alopecia—Carmustine—malignant glioma	0.00522	0.011	CcSEcCtD
Gentamicin—Erythema—Carmustine—malignant glioma	0.00515	0.0108	CcSEcCtD
Gentamicin—Alopecia—Temozolomide—malignant glioma	0.00505	0.0106	CcSEcCtD
Gentamicin—Erythema—Temozolomide—malignant glioma	0.00497	0.0105	CcSEcCtD
Gentamicin—LRP2—Metabolism—RTEL1—malignant glioma	0.00484	0.0238	CbGpPWpGaD
Gentamicin—Anaemia—Carmustine—malignant glioma	0.00476	0.01	CcSEcCtD
Gentamicin—Leukopenia—Carmustine—malignant glioma	0.00461	0.0097	CcSEcCtD
Gentamicin—Anaemia—Temozolomide—malignant glioma	0.0046	0.00968	CcSEcCtD
Gentamicin—Vertigo—Temozolomide—malignant glioma	0.00447	0.00941	CcSEcCtD
Gentamicin—Convulsion—Carmustine—malignant glioma	0.00446	0.00939	CcSEcCtD
Gentamicin—Leukopenia—Temozolomide—malignant glioma	0.00445	0.00937	CcSEcCtD
Gentamicin—Hypertension—Carmustine—malignant glioma	0.00444	0.00935	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—TNF—malignant glioma	0.00443	0.0218	CbGpPWpGaD
Gentamicin—Convulsion—Temozolomide—malignant glioma	0.00431	0.00907	CcSEcCtD
Gentamicin—Hypertension—Temozolomide—malignant glioma	0.00429	0.00904	CcSEcCtD
Gentamicin—Confusional state—Carmustine—malignant glioma	0.00423	0.00891	CcSEcCtD
Gentamicin—Arthralgia—Temozolomide—malignant glioma	0.00423	0.00891	CcSEcCtD
Gentamicin—Thrombocytopenia—Carmustine—malignant glioma	0.00411	0.00866	CcSEcCtD
Gentamicin—Confusional state—Temozolomide—malignant glioma	0.00409	0.00861	CcSEcCtD
Gentamicin—Anaphylactic shock—Temozolomide—malignant glioma	0.00406	0.00854	CcSEcCtD
Gentamicin—Thrombocytopenia—Temozolomide—malignant glioma	0.00397	0.00837	CcSEcCtD
Gentamicin—Hypotension—Carmustine—malignant glioma	0.00392	0.00826	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00383	0.00805	CcSEcCtD
Gentamicin—Paraesthesia—Carmustine—malignant glioma	0.00377	0.00794	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.0037	0.00778	CcSEcCtD
Gentamicin—Decreased appetite—Carmustine—malignant glioma	0.00365	0.00769	CcSEcCtD
Gentamicin—Paraesthesia—Temozolomide—malignant glioma	0.00364	0.00767	CcSEcCtD
Gentamicin—Decreased appetite—Temozolomide—malignant glioma	0.00353	0.00743	CcSEcCtD
Gentamicin—Feeling abnormal—Carmustine—malignant glioma	0.00346	0.00729	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00346	0.017	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—LATS2—malignant glioma	0.00344	0.0169	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00335	0.0165	CbGpPWpGaD
Gentamicin—Feeling abnormal—Temozolomide—malignant glioma	0.00334	0.00704	CcSEcCtD
Gentamicin—Body temperature increased—Carmustine—malignant glioma	0.00332	0.00699	CcSEcCtD
Gentamicin—Urticaria—Temozolomide—malignant glioma	0.00322	0.00679	CcSEcCtD
Gentamicin—Body temperature increased—Temozolomide—malignant glioma	0.00321	0.00675	CcSEcCtD
Gentamicin—Hypersensitivity—Carmustine—malignant glioma	0.00309	0.00651	CcSEcCtD
Gentamicin—Hypersensitivity—Temozolomide—malignant glioma	0.00299	0.00629	CcSEcCtD
Gentamicin—Pruritus—Temozolomide—malignant glioma	0.00287	0.00604	CcSEcCtD
Gentamicin—LRP2—Metabolism—COX8A—malignant glioma	0.00278	0.0137	CbGpPWpGaD
Gentamicin—Dizziness—Carmustine—malignant glioma	0.00278	0.00585	CcSEcCtD
Gentamicin—Dizziness—Temozolomide—malignant glioma	0.00268	0.00565	CcSEcCtD
Gentamicin—Vomiting—Carmustine—malignant glioma	0.00267	0.00562	CcSEcCtD
Gentamicin—LRP2—Disease—BCAN—malignant glioma	0.00265	0.0131	CbGpPWpGaD
Gentamicin—Rash—Carmustine—malignant glioma	0.00265	0.00557	CcSEcCtD
Gentamicin—Dermatitis—Carmustine—malignant glioma	0.00265	0.00557	CcSEcCtD
Gentamicin—Headache—Carmustine—malignant glioma	0.00263	0.00554	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—LATS1—malignant glioma	0.00261	0.0128	CbGpPWpGaD
Gentamicin—Vomiting—Temozolomide—malignant glioma	0.00258	0.00543	CcSEcCtD
Gentamicin—Rash—Temozolomide—malignant glioma	0.00256	0.00539	CcSEcCtD
Gentamicin—Dermatitis—Temozolomide—malignant glioma	0.00256	0.00538	CcSEcCtD
Gentamicin—Headache—Temozolomide—malignant glioma	0.00254	0.00535	CcSEcCtD
Gentamicin—Nausea—Carmustine—malignant glioma	0.00249	0.00525	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00248	0.0122	CbGpPWpGaD
Gentamicin—Nausea—Temozolomide—malignant glioma	0.00241	0.00507	CcSEcCtD
Gentamicin—LRP2—Disease—DTX1—malignant glioma	0.0024	0.0118	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ASMT—malignant glioma	0.00236	0.0116	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00231	0.0114	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—BCAN—malignant glioma	0.00222	0.0109	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00191	0.00939	CbGpPWpGaD
Gentamicin—LRP2—Disease—HEY2—malignant glioma	0.00188	0.00927	CbGpPWpGaD
Gentamicin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00188	0.00925	CbGpPWpGaD
Gentamicin—LRP2—Disease—IDH1—malignant glioma	0.00184	0.00906	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—IDH2—malignant glioma	0.00179	0.00882	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MDK—malignant glioma	0.00176	0.00867	CbGpPWpGaD
Gentamicin—LRP2—Disease—HEY1—malignant glioma	0.00174	0.00858	CbGpPWpGaD
Gentamicin—LRP2—Disease—HIST1H3B—malignant glioma	0.00169	0.00834	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.00169	0.00832	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP2B6—malignant glioma	0.00168	0.00829	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—DTX1—malignant glioma	0.00168	0.00827	CbGpPWpGaD
Gentamicin—LRP2—Disease—JAG2—malignant glioma	0.00155	0.00761	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—IDH1—malignant glioma	0.00154	0.00758	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SPHK1—malignant glioma	0.00149	0.00734	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP2C18—malignant glioma	0.00146	0.00719	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00138	0.00678	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SUFU—malignant glioma	0.00133	0.00657	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HEY2—malignant glioma	0.00132	0.00649	CbGpPWpGaD
Gentamicin—LRP2—Disease—H3F3A—malignant glioma	0.00131	0.00644	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GFAP—malignant glioma	0.00129	0.00634	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.00125	0.00618	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SPHK1—malignant glioma	0.00125	0.00614	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00125	0.00614	CbGpPWpGaD
Gentamicin—LRP2—Disease—JAG1—malignant glioma	0.00123	0.00607	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HEY1—malignant glioma	0.00122	0.00601	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCR4—malignant glioma	0.00122	0.00601	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.00121	0.00596	CbGpPWpGaD
Gentamicin—LRP2—Disease—FBXW7—malignant glioma	0.00121	0.00595	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HIST1H3B—malignant glioma	0.00119	0.00584	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTT1—malignant glioma	0.00118	0.00581	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00114	0.00561	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTGS1—malignant glioma	0.00111	0.00545	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.0011	0.00543	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—JAG2—malignant glioma	0.00108	0.00533	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—BCHE—malignant glioma	0.00103	0.00507	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SLC5A5—malignant glioma	0.00102	0.005	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000996	0.0049	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—APOD—malignant glioma	0.000969	0.00477	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000961	0.00473	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000952	0.00469	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN2B—malignant glioma	0.000947	0.00466	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—H3F3A—malignant glioma	0.000916	0.00451	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCR3—malignant glioma	0.000907	0.00447	CbGpPWpGaD
Gentamicin—LRP2—Disease—HES1—malignant glioma	0.000903	0.00445	CbGpPWpGaD
Gentamicin—LRP2—Disease—NCOR1—malignant glioma	0.000898	0.00442	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000896	0.00441	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—YWHAE—malignant glioma	0.000882	0.00435	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NTRK2—malignant glioma	0.000882	0.00435	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FLT1—malignant glioma	0.000878	0.00433	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—DUSP6—malignant glioma	0.000875	0.00431	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—JAG1—malignant glioma	0.000863	0.00425	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NOTCH3—malignant glioma	0.00086	0.00424	CbGpPWpGaD
Gentamicin—LRP2—Disease—PDGFRA—malignant glioma	0.00086	0.00423	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000853	0.0042	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FBXW7—malignant glioma	0.000846	0.00417	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.00083	0.00409	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—BDKRB2—malignant glioma	0.00083	0.00409	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTP1—malignant glioma	0.000818	0.00403	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CAT—malignant glioma	0.000796	0.00392	CbGpPWpGaD
Gentamicin—LRP2—Disease—TERT—malignant glioma	0.000791	0.0039	CbGpPWpGaD
Gentamicin—LRP2—Disease—HLA-A—malignant glioma	0.000791	0.0039	CbGpPWpGaD
Gentamicin—LRP2—Disease—PDGFB—malignant glioma	0.000772	0.0038	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NOTCH2—malignant glioma	0.000771	0.0038	CbGpPWpGaD
Gentamicin—LRP2—Disease—FGFR1—malignant glioma	0.000768	0.00378	CbGpPWpGaD
Gentamicin—LRP2—Disease—HIF1A—malignant glioma	0.000757	0.00373	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KNG1—malignant glioma	0.000755	0.00372	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NCOR1—malignant glioma	0.000752	0.0037	CbGpPWpGaD
Gentamicin—LRP2—Disease—CAV1—malignant glioma	0.000732	0.00361	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NTRK1—malignant glioma	0.000719	0.00354	CbGpPWpGaD
Gentamicin—LRP2—Disease—BAD—malignant glioma	0.000688	0.00339	CbGpPWpGaD
Gentamicin—LRP2—Disease—NOTCH1—malignant glioma	0.000682	0.00336	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP3—malignant glioma	0.000669	0.00329	CbGpPWpGaD
Gentamicin—LRP2—Disease—CD80—malignant glioma	0.000668	0.00329	CbGpPWpGaD
Gentamicin—LRP2—Disease—APC—malignant glioma	0.000667	0.00328	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN2B—malignant glioma	0.000663	0.00326	CbGpPWpGaD
Gentamicin—LRP2—Disease—EGF—malignant glioma	0.000659	0.00325	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTPN11—malignant glioma	0.000655	0.00323	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTK2—malignant glioma	0.000644	0.00317	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HES1—malignant glioma	0.000632	0.00311	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NCOR1—malignant glioma	0.000629	0.0031	CbGpPWpGaD
Gentamicin—LRP2—Disease—BRAF—malignant glioma	0.000627	0.00309	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CAV1—malignant glioma	0.000613	0.00302	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT2—malignant glioma	0.00061	0.003	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PDGFRA—malignant glioma	0.000602	0.00297	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CD—malignant glioma	0.000586	0.00289	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000586	0.00288	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SPP1—malignant glioma	0.000585	0.00288	CbGpPWpGaD
Gentamicin—LRP2—Disease—FGF2—malignant glioma	0.000561	0.00276	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CG—malignant glioma	0.000558	0.00275	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TERT—malignant glioma	0.000554	0.00273	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PDGFB—malignant glioma	0.000541	0.00266	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PPARG—malignant glioma	0.000539	0.00265	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGFR1—malignant glioma	0.000538	0.00265	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HIF1A—malignant glioma	0.00053	0.00261	CbGpPWpGaD
Gentamicin—LRP2—Disease—MDM2—malignant glioma	0.000525	0.00259	CbGpPWpGaD
Gentamicin—LRP2—Disease—RAF1—malignant glioma	0.000523	0.00258	CbGpPWpGaD
Gentamicin—LRP2—Disease—ERBB2—malignant glioma	0.000518	0.00255	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CAV1—malignant glioma	0.000513	0.00252	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CB—malignant glioma	0.000511	0.00252	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KDR—malignant glioma	0.000507	0.0025	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTGS2—malignant glioma	0.000506	0.00249	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000496	0.00244	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CD—malignant glioma	0.000491	0.00242	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FN1—malignant glioma	0.000488	0.0024	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—F2—malignant glioma	0.000488	0.0024	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—BAD—malignant glioma	0.000482	0.00237	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NOTCH1—malignant glioma	0.000477	0.00235	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CD80—malignant glioma	0.000468	0.0023	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APC—malignant glioma	0.000467	0.0023	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CG—malignant glioma	0.000467	0.0023	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EGF—malignant glioma	0.000461	0.00227	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTPN11—malignant glioma	0.000459	0.00226	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000455	0.00224	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTEN—malignant glioma	0.000441	0.00217	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—BRAF—malignant glioma	0.000439	0.00216	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000433	0.00213	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CB—malignant glioma	0.000428	0.00211	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT2—malignant glioma	0.000427	0.0021	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTGS2—malignant glioma	0.000424	0.00209	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CD—malignant glioma	0.00041	0.00202	CbGpPWpGaD
Gentamicin—LRP2—Disease—STAT3—malignant glioma	0.000395	0.00194	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGF2—malignant glioma	0.000393	0.00194	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTEN—malignant glioma	0.00037	0.00182	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MDM2—malignant glioma	0.000368	0.00181	CbGpPWpGaD
Gentamicin—LRP2—Disease—MYC—malignant glioma	0.000367	0.00181	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RAF1—malignant glioma	0.000366	0.0018	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ERBB2—malignant glioma	0.000362	0.00179	CbGpPWpGaD
Gentamicin—LRP2—Disease—EGFR—malignant glioma	0.000359	0.00177	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CB—malignant glioma	0.000358	0.00176	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCL8—malignant glioma	0.000344	0.00169	CbGpPWpGaD
Gentamicin—LRP2—Disease—KRAS—malignant glioma	0.000339	0.00167	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CASP3—malignant glioma	0.000329	0.00162	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL2—malignant glioma	0.000329	0.00162	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CA—malignant glioma	0.000311	0.00153	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP9—malignant glioma	0.000311	0.00153	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTEN—malignant glioma	0.000309	0.00152	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VEGFA—malignant glioma	0.000279	0.00138	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT3—malignant glioma	0.000276	0.00136	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CA—malignant glioma	0.000261	0.00128	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MYC—malignant glioma	0.000257	0.00127	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT1—malignant glioma	0.000254	0.00125	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EGFR—malignant glioma	0.000251	0.00124	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KRAS—malignant glioma	0.000237	0.00117	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CA—malignant glioma	0.000218	0.00107	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AKT1—malignant glioma	0.000213	0.00105	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TP53—malignant glioma	0.000211	0.00104	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000196	0.000968	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT1—malignant glioma	0.000178	0.000877	CbGpPWpGaD
